Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia

Archives of Medical Research

Volumn 37, Issue 4, 2006, Pages 484-489

  JunHui, Zhu ^a   XingXiang, Wang ^a   JunZhu, Chen ^a   Jian, Sun ^a   FuRong, Zhang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Atherosclerosis; Endothelial progenitor cells; Endothelium; Hyperhomocysteinemia; Stem cells

Indexed keywords

CD133 ANTIGEN; FIBRONECTIN; FLUORESCENT DYE; HOMOCYSTEINE; LECTIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD; CELL ACTIVITY; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; IN VITRO STUDY; MALE; STEM CELL;

AGED; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; STEM CELLS;

EID: 33646049677     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.09.017     Document Type: Article

References (28)

1. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
2. McCully K.S. Homocysteine and vascular disease. Nat Med 2 (1996) 386-389
3. Welch G.N., and Loscalzo J.N. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
4. Duell P.B., and Malinow M.R. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 8 (1997) 28-34
5. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med 49 (1998) 31-62
6. Weiss N., Heydrick S., Zhang Y.Y., Bierl C., Cap A., and Loscalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine β-synthase-deficient mice. Arterioscler Thromb Vasc Biol 22 (2002) 34-41
7. Schlaich M.P., John S., Jacobi J., Lackner K.J., and Schmieder R.E. Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients. Atherosclerosis 153 (2000) 383-389
8. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106 (2000) 483-491
9. Morita H., Kurihara H., Yoshida S., Saito Y., Shindo T., Oh-Hashi Y., et al. Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 103 (2001) 133-139
10. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
11. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
12. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 275 (1997) 964-967
13. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
14. + endothelial precursor cells. Circ Res 88 (2001) 167-174
15. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105 1 (2000) 17-19
16. Szmitko P.E., Fedak P.W., Weisel R.D., Stewart D.J., Kutryk M.J., and Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107 (2003) 3093-3100
17. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
18. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
19. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
20. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
21. Chen J.Z., Zhu J.H., Wang X.X., Zhu J.H., Xie X.D., Sun J., et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 36 (2004) 233-239
22. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12 (1992) 279-298
23. Shipchandler M.T., and Moore E.G. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 41 (1995) 991-994
24. Zhu J.H., Wang X.X., Chen J.Z., Shang Y.P., Zhu J.H., Guo X.G., et al. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol Sin 25 (2004) 1045-1051
25. Rehman J., Li J., Parvathaneni L., Karlsson G., Panchal V.R., Temm C.J., et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43 (2004) 2314-2318
26. Suzuki T., Nishida M., Futami S., Fukino K., Amaki T., Aizawa K., et al. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc Res 58 (2003) 487-492
27. Murayama T., Tepper O.M., Silver M., Ma H., Losordo D.W., Isner J.M., et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol 30 (2002) 967-972
28. Tepper O.M., Galiano D.R., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type 2 diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786